Table 3.
Baseline
|
Follow-up
|
|||||||
---|---|---|---|---|---|---|---|---|
n | Exercisers Geometric Mean (95% CI) | n | Controls Geometric Mean (95% CI) | n | Exercisers Geometric Mean (95% CI) | n | Controls Geometric Mean (95% CI) | |
Men | ||||||||
BMI < 30 kg/m2 | 26 | 0.85 (0.63–1.14) | 26 | 0.89 (0.61–1.30) | 22 | 0.82 (0.62–1.08) | 26 | 0.74 (0.54–1.01)
† p-value: 0.61 |
BMI ≥ 30 kg/m2 | 23 | 1.67 (1.24–2.25) | 23 | 1.57 (1.03–2.39) | 24 | 1.80 (1.25–2.59) | 25 | 1.40 (0.92–2.15)
† p-value: 0.38 |
Women | ||||||||
BMI < 30 kg/m2 | 29 | 1.32 (0.88–1.99) | 30 | 1.60 (1.07–2.38) | 28 | 1.27 (0.86–1.89) | 29 | 1.59 (1.04–2.45)
† p-value: 0.82 |
BMI ≥ 30 kg/m2 | 19 | 4.14 (2.68–6.39) | 19 | 3.47 (2.20–5.47) | 17 | 3.54 (2.33–5.38) | 19 | 3.44 (2.29–5.16)
† p-value: 0.73 |
P-value for difference in CRP changes from baseline to twelve months in exercise intervention versus control stratified by BMI group, controlling for baseline CRP values.